WTKN

 
Common Stock SEC Reporting - Delinquent
OTC Pink No Information
Contact Info
  • 1030 North Orange Ave.
  • Ste. 300
  • Orlando, FL 32801

Business Description

Not Available


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Not Available
Latest Report Sep 30, 2010 10-Q
CIK 0001456453
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 5912 - Drugstores and Proprietary Stores
Business Status Development Stage Company a/o
Incorporated In: NV, USA
Year of Inc. 2009
Employees 33 a/o Feb 16, 2010
Company Officers/Contacts
Randy Lubinsky CEO
Vladimir Kravchenko President
Mark Szporka CFO
Peter Sidorenko Senior VP
Company Directors
Vladimir Kravchenko
Company Notes
  • Formerly=Pharmacity Corp. until 11-2009
Service Providers
Accounting/Auditing Firm
Jewett, Schwartz, Wolfe and Associates
200 South Park Road
Suite 150
Hollywood, FL, 33021
United States

Legal Counsel
Roetzel and Andress, LPA
350 E Las Olas
Suite 1150
Fort Lauderdale, FL, 33394
United States

Investor Relations Firm
Not Available
WTKN Security Details
Share Structure
Market Value1 $54,020 a/o Dec 02, 2016
Authorized Shares 400,000,000 a/o Dec 02, 2010
Outstanding Shares 5,402,000 a/o Dec 02, 2010
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.00001
Transfer Agent(s)
Signature Stock Transfer, Inc.
Shareholders
Shareholders of Record 122 a/o Apr 29, 2010
Short Selling Data
Short Interest 0 (-100%)
May 31, 2011
Significant Failures to Deliver No

1Market Value calculated only for respective security